Pharmacist-led continuous glucose monitoring for type 2 diabetes
Investigating the Impact of Pharmacist-led Flash Continuous Glucose Monitoring on Clinical and Behavioral Health Outcomes
University of South Florida · NCT06572306
This study is testing if having a pharmacist help with continuous glucose monitoring can improve blood sugar control and healthy habits for people with type 2 diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of South Florida (other) |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT06572306 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to evaluate the effects of pharmacist-led continuous glucose monitoring on glycemic control and health behavior changes in individuals with type 2 diabetes. Participants will be monitored using the FreeStyle Libre 2 Continuous Glucose Monitor, and their hemoglobin A1c levels will be compared to those using traditional self-monitoring methods. The study will assess both glycemic outcomes and changes in health behaviors among the intervention group. It is designed as a prospective cohort study to gather data on the effectiveness of this approach.
Who should consider this trial
Good fit: Ideal candidates include adults with type 2 diabetes and hemoglobin A1c levels of 8% or higher who have access to compatible smartphones and glucometers.
Not a fit: Patients who have used a continuous glucose monitor in the past six months or have certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve glycemic control and health behaviors in patients with type 2 diabetes.
How similar studies have performed: Other studies have shown promising results with pharmacist-led interventions in diabetes management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * type 2 diabetes * hemoglobin A1c ≥ 8% * compatible smartphone with FreeStyle Libre 2 or Libre 3+ continuous glucose monitoring system * current use and access to a glucometer for self-monitoring of blood glucose Exclusion Criteria: * any continuous glucose monitor use within 6 months prior to study enrollment * pregnant and planning to become pregnant during study time frame * history of hypoglycemia requiring third party assistance * history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment * known allergy to medical grade adhesives * current use of systemic steroids for any medical condition * current use of dialysis
Where this trial is running
Tampa, Florida
- USF Health Department of Family Medicine — Tampa, Florida, United States (RECRUITING)
Study contacts
- Principal investigator: Kevin Cowart, PharmD, MPH — University of South Florida
- Study coordinator: Kevin Cowart, PharmD, MPH
- Email: kcowart2@usf.edu
- Phone: 813-974-5562
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes, type 2 diabetes, endocrine disorders, continuous glucose monitor, pharmacist